OCGN · NASDAQ · Biotechnology

Ocugen

Develops modifier gene therapies for inherited and degenerative blindness diseases.

$1.35
After-hours close+0.03 (+2.27%)
At close$1.32(−3.65%)

Breakdown13F · Form 4

Institutions 43.23%146.58M sharesInsiders 2.02%6.87M sharesOther 54.75%185.66M shares

Shares outstanding 339.11M · Float 315.73M · 93.1% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
BlackRock, Inc.26.95M8.00%13GJul 29, 2026
State Street Corporation21.47M6.30%13GAug 7, 2026
Janus Henderson Group PLC20.00M6.00%13GDec 8, 2025
Vanguard Capital Management LLC14.37M4.24%13FAug 13, 2026
Millennium Management LLC13.94M4.11%13FAug 14, 2026

Institutions13F, as of Jun 30, 2026

158 holders · 146.58M shares · 47 new positions · 92 increased · 30 reduced · 32 closed

HolderShares% outstandingChg q/qFiled
BlackRock, Inc.27.00M7.96%+19.70MAug 7, 2026
State Street Corp21.47M6.33%+11.80MAug 7, 2026
Vanguard Capital Management LLC14.37M4.24%+568.5KAug 13, 2026
Millennium Management LLC13.94M4.11%+216.1KAug 14, 2026
Geode Capital Management, LLC8.87M2.62%+4.64MAug 12, 2026
RTW Investments, LP6.67M1.97%0Aug 14, 2026
UBS Group AG5.18M1.53%−2.10MAug 13, 2026
Ikarian Capital, LLC3.96M1.17%0Aug 14, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
BlackRock, Inc.8.00%26.95M13GJul 29, 2026
State Street Corporation6.30%21.47M13GAug 7, 2026
Janus Henderson Group PLC6.00%20.00M13GDec 8, 2025
Millennium Management LLC5.20%17.07M13GApr 14, 2026

InsidersForm 4

InsiderRoleShares% outstandingFiled
Shankar Musunuridirector, officer: Chief Executive Officer4.96M1.46%Jan 6, 2026
Junge Zhangdirector1.18M0.35%Apr 2, 2026
Treerita Essalima Johnson-Greeneofficer: Chief Financial Officer521.4K0.15%Jun 17, 2026
Ramesh Ramachandranofficer: Chief Accounting Officer209.1K0.06%Jan 6, 2026

4 ten-percent owners hold 157.4K shares by Form 4, outside the officers-and-directors figure above · 17 people have not refiled in the last 18 months (1.96M shares), so they are not in the figure above

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Jun 15, 2026
Treerita Essalima Johnson-Greeneofficer: Chief Financial Officer
Purchase21,000$1.23521,000

CongressHouse and Senate disclosures

Not reported.